Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$513M |
| 2 |
Medtronic
MDT
|
+$477M |
| 3 |
Apple
AAPL
|
+$403M |
| 4 |
L3Harris
LHX
|
+$334M |
| 5 |
Danaher
DHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$433M |
| 2 |
AbbVie
ABBV
|
+$350M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
+$315M |
| 4 |
CoStar Group
CSGP
|
+$273M |
| 5 |
Abbott
ABT
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Vanguard FTSE Europe ETF
VGK
$30.1B
| $4.96M | ﹤0.01% |
92,607
-11,893
| -11% | -$636K |
|
|
LSI
1052
DELISTED
Life Storage, Inc.
LSI
| $4.96M | ﹤0.01% |
70,506
-43,373
| -38% | -$2.95M |
|
|
DAY
1053
DELISTED
Dayforce
DAY
| $4.92M | ﹤0.01% |
+99,607
| New | +$5.2M |
|
1054
Fluor
FLR
$7.22B
| $4.91M | ﹤0.01% |
256,388
-234,822
| -48% | -$5.61M |
|
1055
Liberty Global Class C
LBTYK
$3.27B
| $4.88M | ﹤0.01% |
205,092
+34,036
| +20% | +$886K |
|
1056
Herbalife
HLF
$1.26B
| $4.87M | ﹤0.01% |
128,585
-221,970
| -63% | -$8.67M |
|
|
BBL
1057
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $4.86M | ﹤0.01% |
113,510
| – | – |
|
1058
Globant
GLOB
$1.41B
| $4.86M | ﹤0.01% |
+53,066
| New | +$5.27M |
|
1059
Vanguard S&P 500 ETF
VOO
$968B
| $4.8M | ﹤0.01% |
17,603
+1,157
| +7% | +$314K |
|
1060
BCE
BCE
$19.8B
| $4.77M | ﹤0.01% |
98,445
-1,668
| -2% | -$78K |
|
1061
Pembina Pipeline
PBA
$29B
| $4.75M | ﹤0.01% |
127,886
-84,132
| -40% | -$3.12M |
|
1062
Ares Management
ARES
$28.8B
| $4.68M | ﹤0.01% |
+174,534
| New | +$4.99M |
|
1063
Rithm Capital
RITM
$5.15B
| $4.62M | ﹤0.01% |
294,841
+27,214
| +10% | +$407K |
|
1064
Restaurant Brands International
QSR
$25.8B
| $4.58M | ﹤0.01% |
64,409
-2,048
| -3% | -$151K |
|
1065
Teva Pharmaceuticals
TEVA
$36.2B
| $4.58M | ﹤0.01% |
665,648
-688,287
| -51% | -$5.27M |
|
1066
Arcus Biosciences
RCUS
$3.5B
| $4.56M | ﹤0.01% |
500,654
-6,875
| -1% | -$55.2K |
|
1067
Acuity Brands
AYI
$10.1B
| $4.55M | ﹤0.01% |
33,758
+3,379
| +11% | +$440K |
|
1068
Vanguard Total International Bond ETF
BNDX
$82.2B
| $4.53M | ﹤0.01% |
76,991
+9,527
| +14% | +$556K |
|
1069
Charles River Laboratories
CRL
$10.8B
| $4.42M | ﹤0.01% |
33,367
-37,309
| -53% | -$5M |
|
1070
Quanta Services
PWR
$93.1B
| $4.39M | ﹤0.01% |
116,283
-54,019
| -32% | -$1.95M |
|
|
IPG
1071
DELISTED
Interpublic Group of Companies
IPG
| $4.38M | ﹤0.01% |
203,286
-1,583
| -0.8% | -$34.2K |
|
1072
Health Catalyst
HCAT
$159M
| $4.37M | ﹤0.01% |
+138,033
| New | +$5.43M |
|
|
NOAH
1073
Noah Holdings
NOAH
$595M
| $4.35M | ﹤0.01% |
148,983
-295,417
| -66% | -$9.42M |
|
1074
Magna International
MGA
$18.3B
| $4.28M | ﹤0.01% |
80,253
-1,115
| -1% | -$55.6K |
|
|
SPLK
1075
DELISTED
Splunk Inc
SPLK
| $4.2M | ﹤0.01% |
35,671
-11,652
| -25% | -$1.46M |
|
Similar funds
Janus Henderson Group's Q3 2019 Portfolio in Review
As of Q3 2019, Janus Henderson Group held 1,465 positions worth $185B, up 0.14% from $184B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q3 2019 filing shows 95 new, 675 increased, 602 reduced and 67 closed positions. Its largest new stake was Medtronic: 4,571,875 shares worth $497M. The largest sale was Mastercard, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2019 buy was Medtronic: 4,571,875 shares worth $497M.
- Janus Henderson Group added most to Fidelity National Information Services in Q3 2019, an estimated $513M increase.
- Janus Henderson Group's biggest Q3 2019 reduction was Mastercard, cutting an estimated $433M.
- Janus Henderson Group fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $315M.
- Janus Henderson Group's ten largest holdings make up 17% of its $185B portfolio in Q3 2019.
- Janus Henderson Group opened 95 new positions and closed 67 in Q3 2019.
- Janus Henderson Group's portfolio value rose 0.14% quarter-over-quarter to $185B.
Based on Janus Henderson Group's 13F filing for Q3 2019, filed 14 Nov 2019.